| Active-Ingredient | Erlotinib |
|---|---|
| Indication | Non-small cell lung cancer, Pancreatic cancer |
| Manufacturers | Cipla Limited |
| Packaging | 30 tablets in 1 bottle |
| Strength | 150mg |
| Drug Class | Tyrosine Kinase Inhibitor (TKI) / EGFR Inhibitor |
| Dosage Form | Oral Tablet |
| Delivery-Time | 6 To 15 days |
No key features available.
